Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Latrepirdine

No Benefit for Dimebon in Huntington’s

An antihistamine that failed to work in Alzheimer’s disease also fell short of expectations in Huntington’s disease, researchers reported.

In a randomized controlled trial, latrepirdine (Dimebon) didn’t improve cognition or global function compared with placebo, Ray Dorsey, MD, of Johns Hopkins, and colleagues reported online in the Archives of Neurology.

Currently, medications can mitigate… No Benefit for Dimebon in Huntington’s   



Alzheimer’s Disease

dementia decline1 - interviews by magistrates1 - dementia resistant1 - memory disorders program1 - berrios and freeman1 - parkinson's sufferer1 - stress2 - cognitive deficits1 - hay fever1 - cholesterol1 - trouble sleeping1 - perusini1 - dementiaantipsychotic drugs1 - long-term cognitive changes1 - cinnamon1 - alcoholism1 - parkinson's psychosis1 - thomas willis1 - prevention of delirium1 - amentia2 - aerobic exercise1 - cognition function1 - antihypertensive drugs1 - ftd1 - fuller1 - diabetes10 - insulin-like growth factor-11 - haloperidol2 - apoe43 - alzheimers disease center1 -